Board Decisions


Approved by the Board on: 04 April 2017

Decision on the Secretariat’s Recommendation on Additional Funding from the 2014 Allocation

The Board:

  1. Acknowledges the original grant duration, as expressed by either the implementation or budgeted period, of Nigeria malaria and its constituent grants, as described in GF/B36/ER09, was shortened according to the operational flexibility granted to the Secretariat pursuant to GF/B31/DP09 when approved by the Board in January 2015 under GF/B32/EDP05;
  2. Approves the redistribution of funding available to Nigeria malaria, and its constituent grants, under the Board’s approval of additional funding in January 2015 (GF/B32/EDP05) as well as the additional implementation period recommended for Nigeria malaria, and its constituent grants, as listed in Tables 1a and 1b of GF/B36/ER09 and described in GF/B36/ER09, paragraph 1.4;
  3. Acknowledges Nigeria malaria’s constituent grants will be implemented by the proposed Principal Recipients listed in Tables 1a and 1b, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
  4. Affirms the funding available for Nigeria malaria under GF/B32/EDP05 and this decision (a) remains the upper-ceiling amount that may be available for the relevant implementation period of each constituent grant, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and
  5. Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.


See attached table detailing total recommended funding amount for the following grants: NGA-M-CRS, NGA-MNMEP. More on Funding Decisions.